Actimab-A, a CD33-targeted Actinium-225 radioconjugate, drives potent mutation-agnostic efficacy in AML models

Blood Neoplasia · Elsevier

Аннотация

Publication date: Available online 10 November 2026 Source: Blood Neoplasia Author(s): Jason Li, Rubin Jiao, Merve Sahin, Sumit Mukherjee, Lily Lumkong, Kevin J.H. Allen, Karina Peregrina, Debbie Lewis, Kaitlyn H. Ko, Mackenzie E. Malo, Monideepa Roy, Ekaterina Dadachova, Wenbin Xiao, Sheng F. Cai, Shiva Kazerounian, Adeela Kamal

Читать у издателя →

Похожие статьи